Detalhe da pesquisa
1.
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo.
Immunology
; 147(4): 399-413, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26694902
2.
Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
J Immunol
; 193(2): 580-586, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928997
3.
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.
J Immunol
; 192(3): 906-18, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379124
4.
Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets.
Eur Neurol
; 73(3-4): 238-246, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25824054
5.
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial.
Neurol Neuroimmunol Neuroinflamm
; 10(4)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37094998
6.
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Rheumatol Ther
; 9(4): 1017-1030, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352313
7.
Novel human transitional B cell populations revealed by B cell depletion therapy.
J Immunol
; 182(10): 5982-93, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19414749
8.
B cells in the pathogenesis and treatment of rheumatoid arthritis.
Curr Opin Rheumatol
; 22(3): 307-15, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20090526
9.
Intrathecal B-cell activation in LGI1 antibody encephalitis.
Neurol Neuroimmunol Neuroinflamm
; 7(2)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029531
10.
Failure of B Cell Tolerance in CVID.
Front Immunol
; 10: 2881, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921145
11.
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Rheumatol Ther
; 9(4): 1247-1248, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779224
12.
Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
PLoS One
; 10(6): e0128269, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26047509
13.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Sci Transl Med
; 6(248): 248ra106, 2014 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25100740
14.
Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.
J Rheumatol
; 39(6): 1130-8, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22505705
15.
Modulation of molecular imprints in the antigen-experienced B cell repertoire by rituximab.
Arthritis Rheum
; 58(12): 3665-74, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19035487
16.
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
Arthritis Rheum
; 54(8): 2377-86, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16869000
17.
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody.
Arthritis Res Ther
; 7(4): R714-24, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15987473